| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | 10% Owner
2 companies
Smith Patrick W serves as a 10% Owner at IMDX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 9 buys and 436 sells. Those positions are worth an estimated $1.6B at current prices.
Historically, Smith Patrick W's trades have earned a middling insider score of 66/100 across 68 rated trades. Over a 12-month horizon, 45.0% of those trades were profitable, with an average 12-month return of -4.6%.
The biggest single holding is AXON (~$1.6B) as Chief Executive Officer. The recent filings there lean toward selling, a net 2,766,302 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Chief Executive Officer | Sell | 10,000 | $591.04 | $5,910,426.30 | -0.3% | -33.7% | - | ||
| Oct 7, 2025 | Chief Executive Officer | Sell | 12,312 | $712.35 | $8,770,439.49 | -0.4% | -17.3% | - | ||
| Sep 8, 2025 | Chief Executive Officer | Sell | 10,000 | $743.64 | $7,436,415.19 | -0.3% | -25.3% | - | ||
| Aug 11, 2025 | Chief Executive Officer | Sell | 10,000 | $831.29 | $8,312,886.46 | -0.3% | -28.6% | - | ||
| Apr 21, 2025 | Chief Executive Officer | Sell | 10,884 | $538.64 | $5,862,518.63 | -0.4% | +38.7% | - | ||
| Feb 7, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,077,600 | $2.05 | $2,209,080.00 | +60.0% | +41.3% | +264.2% | |
| Feb 4, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 915 | $2.01 | $1,839.40 | - | +37.1% | +211.7% | |
| Jan 30, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 4,198 | $2.01 | $8,437.98 | +0.2% | +53.2% | +224.4% | |
| Jan 14, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 16,055 | $2.12 | $34,114.42 | +0.9% | +32.3% | +218.6% | |
| Dec 26, 2024 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 90,219 | $2.13 | $192,166.47 | +5.4% | +49.3% | +199.1% |